Behavioral Pharmacological Examination of a Novel Buprenorphine Induction Method Among Individuals Who Use Fentanyl | MicrobiomeTrials← Back to trialsNCT06089707
Behavioral Pharmacological Examination of a Novel Buprenorphine Induction Method Among Individuals Who Use Fentanyl
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2024-01-09Est. Completion: 2030-01-01
Enrollment target: 3 participants Locations- Johns Hopkins School of Medicine, Baltimore, Maryland, United States
Other microbiome trials you might be interested in
Opioid UsePainHypogonadism, Male
The aim of this trial is to evaluate whether testosterone replacement results in greater improvement in pain perception,…
Boston, United StatesEst. completion Sep 30, 2027
Opioid CravingOpioid Use DisorderMeasure Development
The purpose of this study is to collect information about opioid craving so that the investigators can develop an opioid…
Baltimore, United StatesCompleted Jul 16, 2026
Rotator Cuff TearsShoulder InjuriesHallux ValgusAnkle ArthropathyClavicle Fracture
Postoperative pain remains undertreated with inadequate analgesic options. Opioids have well-known limitations for both …
La Jolla, United StatesCompleted Jun 12, 2026